A multi-omics blood assay, HCCscreen, demonstrated superior performance for detecting hepatocellular carcinoma (HCC) in patients with hepatic cirrhosis compared with individual bi ...
New research reveals a model to predict chronic immune thrombocytopenia in children at diagnosis. Learn how it could guide ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to detect the earliest ...
The latest analyst update on CareDx centers on a higher US$26 price target alongside an unchanged model fair value of US$24.8 per share. That new target reflects a mixed but generally constructive ...
The secret might be hidden in our blood. Boston researchers in a new study have found that a blood test can predict Alzheimer’s disease progression years before symptoms or brain scan changes. The ...
Personalis, Inc. , a leader in advanced genomics for precision oncology, today announced the successful presentation of clinical data at the American Association for Cancer Research (AACR) Annual ...
Partnership with Perpetuals gives students and researchers across 50+ countries access to a production-grade AI platform and one of the largest ...
Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic ...
In 1993, 25 years after her family launched their foundation, the group of scientists they supported finally identified the ...
Firms like Function Health and Oura market regular blood tests to people wanting to take their health into their own hands.
Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results